Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A recent increase in the incidence of prostatic carcinoma in a French population: role of ultrasonography and prostatic specific antigenF Ménégoz, M Colonna, C Exbrayat, et al.
European Journal of Haematology|October 1, 1989
Role of autologous lymph node T cells in membrane expression of mu- or gamma-heavy chain isotype by malignant B NHL cellsT Bonnefoix, H Orfeuvre, M C Jacob, et al.
Revue Neurologique|January 1, 1993
[Incidents of brain tumors observed in the Grenoble area (canton of Meylan) 1979-1990]H Orfeuvre, J M Lutz, F Menegoz, et al.
Revue Des Maladies Respiratoires|January 1, 1993
[Clinical data and descriptive epidemiology of primary bronchial cancer. 9 years of activity of the Isère Registry]H Orfeuvre, F Menegoz, J M Lutz, et al.
Annales De Biologie Clinique|August 6, 2009
[A severe G6PD deficiency revealed during a chemotherapy protocol including rasburicase]P Joly, C Bon, A Francina, et al.
Bulletin Du Cancer|January 1, 1994
[Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin]D Moro, H Orfeuvre, H Nagy-Mignotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Oral vinorelbine: feasibility and safety profileA Depierre, G Freyer, J Jassem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2006
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trialJ-M Ferrero, B Weber, J-F Geay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO groupS Camilleri-Broët, A C Hardy-Bessard, A Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2009
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLEC de la Fouchardière, R Largillier, Y Goubely, et al.
Pageof 2